Efficacy and effectiveness of influenza vaccination

Vaccine

Volumn 26, Issue SUPPL. 4, 2008, Pages

  Nichol, Kristin L ^a  

^a VA MEDICAL CENTER   (United States)

Author keywords

Influenza; Vaccination; Vaccine effectiveness; Vaccine efficacy

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE;

ARTICLE; COMMUNITY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HOUSEHOLD; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; YOUNG ADULT;

EID: 51449118699     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.07.048     Document Type: Article

References (44)

1. Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory committee on Immunization Practices (ACIP), 2007. MMWR 2007;56 (RR-6):1-53.
2. Centers for Disease Control and Prevention. Estimates of influenza vaccination target population sizes in 2006 and recent vaccine uptake levels. http://www.cdc.gov/flu/professionals/vaccination/pdf/targetpopchart.pdf (accessed 5/4/08).
3. The Macroepidemiology of Influenza Vaccination (MIV) Study Group. The macroepidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 2005;23:5133-43.
4. Nichol K.L. Heterogeneity of influenza case definitions and implications for interpreting and comparing study results. Vaccine 24 (2006) 6726-6728
5. Jacobson R.M., Targonski P.V., and Poland G.A. Meta-analyses in vaccinology. Vaccine 25 (2007) 3153-3159
6. Gotzsche P.C., Hrobjartsson A., Marie K., and Tendal B. Data extraction error in meta-analyses that use standardized mean differences. JAMA 298 (2007) 430-437
7. Villari P., Manzoli L., and Boccia A. Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis. Vaccine 22 (2004) 3475-3486
8. Beyer W.E.P. Heterogeneity of case definitions used in vaccine effectiveness studies-And its impact on meta-analysis. Vaccine 24 (2006) 6602-6604
9. Manzoli L., Schioppa F., Boccia A., and Villari P. The efficacy of influenza vaccine for healthy children. A meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr Infect Dis J 26 (2007) 97-106
10. Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in health children. Cochrane Database of Systematic Reviews 2008; Issue 2.
11. Negri E., Colombo C., Giordano L., Groth L., Apolone G., and Vecchia C.L. Influenza vaccine in health children: a meta-analysis. Vaccine 23 (2005) 2851-2861
12. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 356 (2007) 685-696
13. Ashkenazi S., Vertruyen A., Aristegui J., Esposito S., McKeith D.D., Klemola T., et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediat Infec Dis J 25 (2006) 870-879
14. Fleming D.M., Crovari P., Wahn U., Klemola T., Schlesinger Y., Langussis A., et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 25 (2006) 860-869
15. Jefferson TO, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane database of systematic reviews 2007. Issue 2. Art. no.: CD001269.
16. Nichol K.L., Mendelman P.M., Mallon K.P., Jackson L.A., Gorse G.J., Belshe R.B., et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 282 (1999) 137-144
17. Edwards K.M., Dupont W.D., Westrich M.K., et al. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 169 (1994) 68-76
18. Treanor J.J., Kotloff K., Betts R.F., Belshe R., Newman F., Iacuzio D., et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2) and B viruses. Vaccine 18 (1999) 899-906
19. Ohmit S.E., Victor J.C., Rotthoff J.R., Teich E.R., Truscon R.K., Baum L.L., et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 355 (2006) 2513-2522
20. Govaert T.M., Thijs C.T., Masurel N., Sprenger M.J., Dinant G.J., and Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 272 (1994) 1661-1665
21. Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in the elderly. Cochrane database of systematic reviews 2006; Issue 3, Art. no.: CD004876.
22. Vu T., Farish S., Jenkins M., and Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 20 (2002) 1831-1836
23. Gross P.A., Hermogenes A.W., Sacks H.S., Lan J., and Levandowski R.A. The efficacy of influenza vaccine in elderly persons. A meta analysis and review of the literature. Ann Intern Med 123 (1995) 518-527
24. Simonsen L., Taylor R.J., Viboud C., Miller M.A., and Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7 (2007) 658-666
25. Grimes D.A., and Schulz K.F. Bias and causal associations in observational research. Lancet 359 (2002) 248-252
26. Hak E., Verheij T.J., Grobbee D.E., Nichol K.L., and Hoes A.W. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health 56 (2002) 951-955
27. Nichol K.L., Nordin J.D., Nelson D.B., Mullooly J.P., and Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 357 (2007) 1373-1381
28. Ortqvist A., Granath F., Askling J., and Hedlune J. Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area. Eur Respir J 30 (2007) 414-422
29. Nichol K.L. Influenza vaccination in the elderly. Impact on hospitalization and mortality. Drugs Aging 22 (2005) 495-515
30. Hak E., Busken E., van Essen G.A., de Balker D.H., Grobbee D.E., Tacken M.A., et al. Clinical effectiveness of influenza vaccination in persons younger that 65 years with high-risk medical conditions. The PRISMA study. Arch Intern Med 165 (2005) 274-280
31. Poole PJ, Chacko E, Wood-Baker RWB, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. no.: CD002733.
32. Cates CJ, Jefferson TO, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD000364.
33. Stashili J., Kalilani L., and Adimora A.A. Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis. BMC Infect Dis 6 (2006) 138 10.1186/1471-2334-6-138
34. Anema A., Mills E., Montaner J., Brownstein J.S., and Cooper C. Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis. HIV Med 9 (2008) 57-61
35. Jordan R., Connock M., Albon E., Fry-Smith A., Olowokne B., Hawker J., and Burls A. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine 24 (2006) 1047-1062
36. Piedra P.A., Gaglani M.J., Kozinetz C.A., Herschler G., Riggs M., Griffith M., et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 23 (2005) 1540-1548
37. King Jr. J.C., Stoddard J.J., Gaglani M.J., Moore K.A., Magder L., McClure E., et al. Effectiveness of school-based influenza vaccination. N Engl J Med 355 (2006) 2523-2532
38. Salgado C.D., Farr B.M., Hall K.K., and Hayden F.G. Influenza in the acute hospital setting. Lancet Infect Dis 2 (2002) 145-155
39. Thomas R., Jefferson T.O., Demicheli V., and Rivetti D. Influenza vaccination for health-care workers who work with elderly people in institutions: a systematic review. Lancet 6 (2006) 273-279
40. Burls A., Jordan R., Barton P., Olowokne B., Wake B., Albon E., and Hawker J. Vaccinating healthcare workers against influenza to protect the vulnerable-is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine 24 (2006) 4212-4221
41. Hayward A.C., Harling R., Wetten S., Johnson A.M., Munro S., Smedley J., et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ 333 7581 (2006) 1241
42. Nichol K.L., Nordin J.D., and Hak E. Effectiveness of influenza vaccination-correspondence. N Engl J Med 357 (2007) 2730-2731
43. Centers for Disease Control and Prevention. Preliminary assessment of the effectiveness of the 2003-04 inactivated influenza vaccine: Colorado, December 2003. MMWR 2004;53:8-11.
44. Centers for Disease Control and Prevention. Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults: Colorado, 2003. MMWR 2004;53:707-10.